Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome
NCT02691949
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Sjogren's Syndrome
Interventions
DRUG:
Mycophenolate mofetil
Sponsor
Kaohsiung Medical University